Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety and Feasibility Single-Arm Study of a Novel Catheter Thrombectomy Device For the Treatment of Pulmonary Embolism (ENGULF)

NCT05597891 is registered in ClinicalTrials.gov with Endovascular Engineering as lead sponsor.

NCT NCT05597891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05597891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety and Feasibility Single-Arm Study of a Novel Catheter Thrombectomy Device For the Treatment of Pulmonary Embolism (ENGULF)
Lead sponsor
Endovascular Engineering
Phase
Not applicable
Overall status
Completed
Start date
January 12, 2023
Completion date
March 30, 2026
Enrollment
177 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism